ESTRO35 Programme Book

MONDAY 2 MAY 2016

therapy treatment. This will be followed by the merits of intraprostatic fiducial markers and the potential for fiducial migration will be analysed. We conclude our session with an overview of shared decision making and the validation of a decision aid tool for shared decision making in prostate cancer.

Chair: L. Mullaney (Ireland) Co-chair: C. Dionisi (Italy)

14:30 > Bladder variability for pelvic radiotherapy: its approaches and impact Speaker: V. Khoo (UK) 15:00 > An evaluation of GoldAnchor intraprostatic fiducial marker stability during radiotherapy Speaker: D. Bodusz (Poland) 15:30 > Validation of a prostate cancer decision aid tool for shared decision making Speaker: E. Bloemen- van Gurp (The Netherlands)

SP-0507

SP-0508

SP-0509

Poster Viewing 11 CLINICAL: BREAST, HEAD AND NECK

14:30 - 16:00 | POSTER AREA Chair: V. Grégoire (Belgium) Chair: A. Fozza (Italy)

> Evaluation of a breast cancer nomogram to predict local relapse after breast conserving therapy I. Kindts (Belgium), A. Laenen, S. Peeters, H. Janssen, T. Depuydt, E. Van Limbergen, C. Weltens > Hypofractionated VMAT for early stage breast cancer: acute toxicity and cosmesis in 840 patients C. Iftode (Italy), F. De Rose, D. Franceschini, A. Fogliata, E. Villa, A.M. Ascolese, P. Navarria, G.R. D'Agostino, C. Franzese, T. Comito, A. Tozzi, E. Clerici, R.L.E. Liardo, A. Stravato, M. Scorsetti > Accelerated partial breast irradiation for Luminal-A breast cancer: ana- lysis from a phase 3 trial I. Meattini (Italy), C. Saieva, I. Desideri, G. Simontacchi, L. Marrazzo, S. Scoccianti, C. De Luca Cardillo, V. Scotti, P. Bonomo, M. Mangoni, F. Rossi, J. Nori, D. Casella, M. Bernini, L. Sanchez, L. Orzalesi, S. Pallotta, S. Bianchi, L. Livi

PV-0510

PV-0511

PV-0512

SCIENTIFIC PROGRAMME | PROGRAMME AND EXHIBITION GUIDE

139